Spyre Therapeutics, Inc. — Form D
Spyre Therapeutics, Inc. of Waltham, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-07-06. The offering totals $210.0M, of which $210.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-07-06
- Form: D
- Accession: 0001231919-23-000044
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $210.0M
- Amount sold: $210.0M
- Investors: 41
- Date of first sale: 2023-06-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-486102
Issuer
- Name: Spyre Therapeutics, Inc.
- CIK: 0001636282
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 221 Crescent Street, Waltham, MA, 02453
- Phone: 617-651-5940
Officers, directors & promoters (21)
| Name | Role | Location |
|---|
| Ivana J Magovcevic-Liebisch | Director | Austin, TX |
| Hunter C Smith | Director | Austin, TX |
| Jonathan Alspaugh | Executive Officer | Austin, TX |
| Cortney Caudill | Executive Officer | Austin, TX |
| Cameron Turtle | Director | Waltham, MA |
| Cameron Turtle | Executive Officer | Waltham, MA |
| Tomas J Kiselak | Director | Waltham, MA |
| Scott Burrows | Executive Officer | Waltham, MA |
| Laurie J Stelzer | Director | Waltham, MA |
| Russell J Cox | Director | Waltham, MA |
| Peter J Harwin | Director | Waltham, MA |
| Alison J Lawton | Director | Waltham, MA |
| Michael J Henderson | Director | Waltham, MA |
| Heidy King-Jones | Executive Officer | Waltham, MA |
| Jeffrey W Albers | Director | Waltham, MA |
| David G Lowe | Director | Austin, TX |
| David G Lowe | Executive Officer | Austin, TX |
| Armen G Shanafelt | Director | South San Francisco, CA |
| Henry G Skinner | Director | WATERTOWN, MA |
| Charles N York | Executive Officer | Austin, TX |
| George G Georgiou | Director | Austin, TX |
Other filings by this issuer (2)
More